Clin2
NCT07664670Possibly a fitNot yet recruiting

High-fiber eating plan during stem cell transplant

Hematopoietic and Lymphatic System Neoplasm

Part of Blood & lymphatic, Cancer clinical trials.

This study tests a high-fiber diet program to see if it can improve gut health during a stem cell transplant. You may benefit from more stable digestion and a stronger immune system after your transplant.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
44 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are scheduled for a stem cell transplant within the next 6 weeks.
  • You are generally able to care for yourself (performance status of 70% or higher).
  • You don't have a medical condition or dietary restriction that would make eating more fiber unsafe.
  • You can read and understand English for the study questionnaires.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04829136Recruiting
Oral fiber supplement during donor stem cell transplant

This trial tests whether taking a fiber supplement by mouth during a donor stem cell transplant helps patients tolerate treatment and potentially recover better. It’s specifically for adults who are planning a donor (allogeneic) transplant for blood cancers.

Seattle, Washington
NCT06815003Recruiting· Phase 2
Preventing Graft-Versus-Host Disease After Stem Cell Transplant

This trial tests a combination of three drugs (vedolizumab, cyclophosphamide, and tacrolimus) to prevent graft-versus-host disease, a common complication after a donor stem cell transplant. It is for people with certain blood cancers who are getting a reduced-intensity transplant.

Duarte, California
NCT06996119Recruiting· Phase 1
Preventing graft-versus-host disease after stem cell transplant

This trial tests adding a drug called emapalumab to standard medications (cyclophosphamide, tacrolimus, mycophenolate mofetil) to prevent graft-versus-host disease in adults receiving a donor stem cell transplant. This approach aims to reduce complications after transplant.

Duarte, California
NCT06856226Recruiting
Drug metabolism study for stem cell transplant patients

This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.

Bethesda, Maryland
NCT06004063Recruiting
Liquid nutrition vs. usual diet in stem cell transplant patients

This study tests whether giving liquid nutrition through a feeding tube during stem cell transplant is better than the usual diet. The goal is to see if it is safe and can help patients feel better during recovery.

Houston, Texas
NCT07477522Recruiting· Phase 1
High-fiber diet study for solid tumor patients

This trial tests whether eating a high-fiber diet can improve your gut health, metabolism, and immune system. It is for people with solid tumors who are able to eat or use a feeding tube.

Chengdu, Sichuan

Hear when a new Hematopoietic and Lymphatic System Neoplasm trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.